ライフサイエンスコーパス: hyperthermia

1 ir frequently being coordinated (e.g. during hyperthermia).

2 nsitive liposomal doxorubicin and ultrasound hyperthermia.

3 idation and inflammatory response in passive hyperthermia.

4 erature-sensitive doxorubicin and ultrasound hyperthermia.

5 ne, in reversing MDMA-induced brain and body hyperthermia.

6 hyperthermia, particularly in poikilocapnic hyperthermia.

7 red for prospective applications in magnetic hyperthermia.

8 lpha-subtype had no effect on stress-induced hyperthermia.

9 ptoms, including anorexia, hypoactivity, and hyperthermia.

10 both alone and in combination with magnetic hyperthermia.

11 knockout mice are more intolerant of severe hyperthermia.

12 variant" is weakly associated with malignant hyperthermia.

13 olene is the first line therapy of malignant hyperthermia.

14 tion, with syndromes that are exacerbated by hyperthermia.

15 her enhanced the radiosensitizing effects of hyperthermia.

16 Lactulose had no effect on METH-induced hyperthermia.

17 dependent potentiation of MDMA-induced brain hyperthermia.

18 r patients had episodes resembling malignant hyperthermia.

19 VCmax) sites in response to exercise-induced hyperthermia.

20 s greater HIV-1 replication in conditions of hyperthermia.

21 with (eight pigs) or without (eight pigs) RF hyperthermia.

22 an unrecognized susceptibility to malignant hyperthermia.

23 eceptor 1, and were susceptible to malignant hyperthermia.

24 ons are at high risk of developing malignant hyperthermia.

25 e critical for the pathogenesis of malignant hyperthermia.

26 ed to the pharmacogenetic disorder malignant hyperthermia.

27 scattering is optimal for NIR laser-induced hyperthermia.

28 accepted model of thermal damage to cells in hyperthermia.

29 he cerebral oxidative/inflammatory burden of hyperthermia.

30 nd TGR5 bile acid receptors in MDMA-mediated hyperthermia.

31 lesions upon exposure to ultrasound-mediated hyperthermia.

32 resulted in the attenuation of MDMA-induced hyperthermia.

33 iffered significantly following radiation or hyperthermia.

34 elds (AMFs), making them suitable for cancer hyperthermia.

35 s, premature death and seizures triggered by hyperthermia.

36 t size as dobutamine at a given temperature (hyperthermia: -28% +/- 4%, normothermia: -27% +/- 6%, an

37 For the HIFU group, mild hyperthermia (40-42 degrees C) was completed within 90mi

38 ac function, we characterized the effects of hyperthermia (40.5 degrees C), normothermia (38.0 degree

39 In vitro data suggests that mild hyperthermia (41-46 degrees C for ten minutes) is an opt

40 ermia and atmospheric pressure (group 1), or hyperthermia (42 degrees C) and atmospheric pressure (gr

41 onance imaging heating guidewire-mediated RF hyperthermia (42 degrees C) plus local chemotherapy (cis

42 Application of local, mild hyperthermia (42 degrees C) significantly increased the

43 ce cytotoxicity in combination with moderate hyperthermia (43 degrees C, 30 min).

44 e at a pressure of 100 mm Hg: 74 +/- 5 mL at hyperthermia, 52 +/- 4 mL at normothermia, and 41 +/- 3

45 also be considered susceptible to malignant hyperthermia, a life-threatening anesthetic complication

46 hod provides a direct path way of comparison hyperthermia ability of MNPs, and serves as a good refer

47 Four treatment groups were defined: hyperthermia, ablation, hyperthermia followed by ablatio

48 e short-term treatment schedules of drug and hyperthermia administration in a 4T1 breast cancer model

49 nanoparticles (Co-Fe NCs) serve as magnetic hyperthermia agents and as a cytotoxic agent due to the

50 ity of superparamagnetic nanoparticle (SPNP) hyperthermia agents are still remained as critical chall

51 luorouracil), (b) chemotherapy alone, (c) RF hyperthermia alone, and (d) phosphate-buffered saline.

52 Results Compared with chemotherapy alone, RF hyperthermia alone, and phosphate-buffered saline, combi

53 Results Compared with chemotherapy alone, RF hyperthermia alone, and phosphate-buffered saline, combi

54 Here, we asked whether hyperthermia alters the response to chemotherapy-induced

55 al applications of MRgHIFU primarily utilize hyperthermia and ablation to treat cancerous tissue, but

56 c delivery of R848-TSLs, combined with local hyperthermia and alphaPD-1, inhibited tumor growth and e

57 d with congenital diseases such as malignant hyperthermia and central core disease (CCD).

58 g sites of mutations implicated in malignant hyperthermia and central core disease.

59 ng sites of mutation implicated in malignant hyperthermia and central core disease.

60 buffered saline, combination therapy with RF hyperthermia and chemotherapy induced the lowest cell pr

61 buffered saline, combination therapy with RF hyperthermia and chemotherapy induced the lowest cell pr

62 tudied in detail because toxicity, including hyperthermia and death, reduced interest in the clinical

63 ammation, but directly blocking TRPV1 causes hyperthermia and decreased sensitivity to painful levels

64 und that in vitro exposure of tumor cells to hyperthermia and doxorubicin resulted in immunogenic cel

65 important role in the pathology of malignant hyperthermia and heart failure.

66 The role of interleukin-6 (IL-6) in hyperthermia and heat stroke is poorly understood.

67 ycemia; techniques for cooling of exertional hyperthermia and heatstroke; recognition of acute stroke

68 and high pressure (25 cm H2O) (group 3), or hyperthermia and high pressure (group 4).

69 he animals experienced prolonged episodes of hyperthermia and hypothermia; disruptions in their diurn

70 h RFA sensitizes the tumor periphery to mild hyperthermia and increases RFA antitumor efficacy.

71 unique chain formation, along with the mild hyperthermia and intrinsic cobalt toxicity, leads to com

72 APOepsilon3/APOepsilon4 patients had higher hyperthermia and plasma TNF-alpha levels and earlier pla

73 iseases that involve RyRs, such as malignant hyperthermia and polymorphic ventricular tachycardia.

74 f-concept for further evaluation of combined hyperthermia and radiation for GBM treatment.

75 odality therapies such as the combination of hyperthermia and radiation, quantification of biological

76 a potential combinational therapy involving hyperthermia and targeting of the Hippo pathway.

77 role for the gut microbiota in MDMA-mediated hyperthermia and that MDMA treatment can trigger a rapid

78 for biomedical applications such as magnetic hyperthermia and theranostics due to their bio-compatibi

79 us medical interventional procedures such as hyperthermia and thermal ablation.

80 estrin deficient diseases, such as malignant hyperthermia and ventricular tachycardia.

81 acoustic startle, attenuated stress induced hyperthermia, and a blunted increase in startle followin

82 s associated with muscle diseases, malignant hyperthermia, and central core disease.

83 lations are explained in terms of radiation, hyperthermia, and chemo effects.

84 g psychosis, violent behaviors, tachycardia, hyperthermia, and even death.

85 (UCPDK) fail to show methamphetamine-induced hyperthermia, and have a markedly accelerated loss of bo

86 sed heart rate and blood pressure, sweating, hyperthermia, and motor posturing, often in response to

87 t acute CBD (100 mg/kg) treatment attenuated hyperthermia- and acoustically induced seizures in a mou

88 ate localization of photothermal heating for hyperthermia applications for in-vitro and ex-vivo model

89 in magnetic nanoparticles with relevance to hyperthermia applications in biomedicine.

90 critical challenges for successful clinical hyperthermia applications.

91 totoxicity was similarly augmented with mild hyperthermia applied prior to treatment with released Cu

92 The molecular events in response to severe hyperthermia are not fully understood, and research has

93 cal functions of IL-6 and other cytokines in hyperthermia are poorly understood.

94 magnetic particle imaging and magnetic fluid hyperthermia, are highlighted.

95 wax composite capsule coating using magnetic hyperthermia as a release trigger.

96 ffects of radiofrequency (RF) electric-field hyperthermia as an adjunctive therapy to [60]fullerene n

97 e coating, which is activated using magnetic hyperthermia as an on-demand release mechanism to heat a

98 redox potential, over-expressed enzymes and hyperthermia as well as to externally applied stimuli su

99 tial minimally invasive functional malignant hyperthermia assay.

100 RPV1 antagonist, AMG9810, caused significant hyperthermia, associated with increased noradrenaline co

101 adenocarcinoma cell cultures after 1 hour of hyperthermia at 41 degrees C or 43 degrees C with or wit

102 ation treatments of radiation (0-20 Gy), and hyperthermia at 47 degrees C (0-780 CEM(43)) has been ev

103 channel mutations suffer from anhidrosis and hyperthermia at high ambient temperatures.

104 chemotherapy (gemcitabine and 5-FU) plus RF hyperthermia, (b) chemotherapy only, (c) RF hyperthermia

105 anoparticle (MSN) will advance the design of hyperthermia-based nanotheranostics and AMF-stimulated d

106 ncreased AKT activation, but the addition of hyperthermia before radiotherapy reduced AKT activation

107 Furthermore, hyperthermia blocked this histone modification as effici

108 destly effective in attenuating MDMA-induced hyperthermia by moderately inhibiting skin vasoconstrict

109 to the powerful potentiation of MDMA-induced hyperthermia by social interaction and warm ambient temp

110 ary MR imaging heating guidewire-mediated RF hyperthermia can enhance the chemotherapeutic effect on

111 Conclusion Intraesophageal RF hyperthermia can enhance the effect of chemotherapy on e

112 nd extra-vascular space suggest that mild RF hyperthermia can improve nanoparticle delivery into tumo

113 cles of therapeutic agents, such as drugs or hyperthermia-capable nanoparticles, is being intensely i

114 at exposure of a human lymphoid cell line to hyperthermia causes CDK5 insolubilization and loss of ty

115 Moreover, hyperthermia combined with p53 depletion restored both t

116 the presence of all metals within 1 h under hyperthermia conditions, Cu(II) activation produces >50%

117 acheal LPS and then exposed to febrile range hyperthermia (core temperature, approximately 39.5 degre

118 When associated with mild hyperthermia, Dbait induced cytotoxicity in all tested c

119 enotypes, including increased stress-induced hyperthermia, defective spatial learning, impaired gait,

120 Notably, we found that hyperthermia delayed the repair of DNA damage caused by

121 ects in humans, including the development of hyperthermia during acute intoxication.

122 Chronic hyperthermia during lactation was not caused by increase

123 dramatic enhancements of drug-induced brain hyperthermia during social interaction (exposure to male

124 g0.13 -gammaFe2 O3 nanofluids show promising hyperthermia effects to completely kill the tumors.

125 noplatforms were capable of producing strong hyperthermia efforts to kill cancer cells and hela cells

126 Hyperthermia either as standalone treatment or before ab

127 le potential effects on the organism such as hyperthermia, endotoxemia, and/or systemic inflammation.

128 Thus, a more detailed knowledge about how hyperthermia exerts its effects on chemotherapy may illu

129 iterature to obtain a compendium of in vitro hyperthermia experiments investigating the heat-shock re

130 lementation on organ injury following severe hyperthermia exposure in anaesthetized mice.

131 The immune system responds to hyperthermia exposure resulting in heat stroke by produc

132 groups were defined: hyperthermia, ablation, hyperthermia followed by ablation, or no HIFU.

133 ythm, whereas sham-vaccinated animals showed hyperthermia, followed by sustained hypothermia, as well

134 Results show the potential of HIFU-mediated hyperthermia for enhanced delivery of polymer therapeuti

135 es in accurate control of large volume tumor hyperthermia for longer duration (>30min.).

136 parameters needed to deliver volumetric mild hyperthermia for targeted drug delivery without real-tim

137 targeting, gene and drug delivery, magnetic hyperthermia for tumor treatment, and manipulation of th

138 Mild hyperthermia generated using high intensity focused ultr

139 atment drugs after the development of robust hyperthermia (>2.5 degrees C), thus mimicking the clinic

140 Magnetic fluid hyperthermia has been recently considered as a Renaissan

141 ed light to heat and induce highly localized hyperthermia has been shown to be highly effective for p

142 Mild hyperthermia has been used in combination with polymer t

143 Whole-body hyperthermia holds promise as a safe, rapid-acting, anti

144 ure differentials through tissues undergoing hyperthermia, however temperatures can be predicted and

145 ox) with thermosensitive liposomes (TSL) and hyperthermia (HT) has shown preclinically to achieve hig

146 hat rapidly releases DOX in response to mild hyperthermia (HT).

147 included hepatopathy, bifid uvula, malignant hyperthermia, hypogonadotropic hypogonadism, growth reta

148 e of the need to withdraw therapy because of hyperthermia, hypothermia, dehydration, or sunburn.

149 heckpoint inhibitor, and ultrasound-mediated hyperthermia in a neu deletion (NDL) mouse mammary carci

150 o conventional strategies employing magnetic hyperthermia in a radio frequency (RF) AMF.

151 and must be adapted to produce uniform mild hyperthermia in a solid tumor.

152 Plasma IL-6 is elevated following hyperthermia in animals and humans, and IL-6 knockout mi

153 sculature with and without application of RF hyperthermia in each condition.

154 CO2 production (V(CO2)) did not change with hyperthermia in either control or DNE pups.

155 ve for reversing MDMA-induced brain and body hyperthermia in emergency clinical situations, with poss

156 trategies to treat pathological MDMA-induced hyperthermia in humans are palliative and marginally eff

157 tor, can be used to increase cytotoxicity of hyperthermia in in vitro cell lines and the effectivenes

158 rs the ventilatory and metabolic response to hyperthermia in neonatal rats (postnatal age 2-4 days),

159 t alterations in the ventilatory response to hyperthermia in neonatal rats.

160 haracterized by induction of skeletal muscle hyperthermia in response to a dysregulated increase in m

161 nergistic toxicity of Dox and the effects of hyperthermia in vitro on glioblastoma U251-MG cells and

162 -Amphetamine (potent sympathomimetic) caused hyperthermia in WT mice, which was reduced in TRPV1 KO m

163 therapy can improve the effects of magnetic hyperthermia, inaugurating investigation of mechanical b

164 Hyperthermia increases expression of the antiviral cellu

165 It is well-established that hyperthermia increases neuronal death and worsens stroke

166 We found that RF hyperthermia induced a 30-40% increase in Alexa-Albumin

167 Hyperthermia induced by 3,4-methylenedioxymethamphetamin

168 r, liposomal gemcitabine combined with local hyperthermia induced cell death and regions of apoptosis

169 At the molecular level, hyperthermia induced polyploidization by perturbing cent

170 Following hyperthermia, induced expression of cell surface heat sh

171 or bearing mice, a single treatment of tumor hyperthermia, induced via gold nanorod mediated plasmoni

172 nlike radiation, which kills dividing cells, hyperthermia-induced cell death affects cells independen

173 c nanoparticles targeted to a tumor, causing hyperthermia-induced cell death.

174 tible than Scn1b(+/-) and Scn1b(+/+) mice to hyperthermia-induced convulsions, a model of pediatric f

175 which one Fgf13 allele was deleted exhibited hyperthermia-induced seizures and epilepsy.

176 sensitivity to flurothyl-, kainic acid-, and hyperthermia-induced seizures measured a month later dur

177 D7325 elevated the temperature threshold for hyperthermia-induced seizures without apparent sedative

178 SGE-516 treatment protected against hyperthermia-induced seizures, reduced spontaneous seizu

179 ce, we determined the effect of treatment on hyperthermia-induced seizures, spontaneous seizure frequ

180 Additionally, they indicate that hyperthermia induces apoptosis through the insolubilizat

181 However, how hyperthermia induces DNA damage sensitivity is not clear

182 Malignant hyperthermia is a pharmacogenetic disorder typically tri

183 Hyperthermia is a proteotoxic stress that is lethal when

184 Nanoparticle-based magnetic hyperthermia is a well-known thermal therapy platform st

185 ion enzyme superoxide dismutase (SOD) during hyperthermia is an appealing approach to induce death of

186 Our findings show that magnetic hyperthermia is an effective method to kill host-infecti

187 MDMA-induced hyperthermia is highly variable, unpredictable, and grea

188 little is known about the mechanisms of how hyperthermia is involved in this neuronal death process.

189 In radiation oncology, hyperthermia is known to radiosensitize cells, and it is

190 imulating spheroid response to radiation and hyperthermia is presented.

191 Photothermal hyperthermia is proven to be an effective diagnostic too

192 e heat waves to cause lethal dehydration and hyperthermia is well documented, but the consequences of

193 h Brody disease may be at risk for malignant hyperthermia-like episodes, and therefore appropriate pe

194 Consequently, for myeloma, mild hyperthermia may be a beneficial approach to enhance the

195 eral novel drug delivery methods - including hyperthermia, mechanical sustained released devices and

196 The use of magnetic fluid hyperthermia (MFH) for cancer therapy has shown promise

197 Malignant hyperthermia (MH) is a clinical syndrome of skeletal mus

198 Malignant hyperthermia (MH) is characterized by induction of skele

199 Malignant hyperthermia (MH) is linked to mutations in the type 1 r

200 Malignant hyperthermia (MH) is potentially fatal pharmacogenetic d

201 Malignant hyperthermia (MH) susceptibility has been attributed to

202 mutations confer stress-triggered malignant hyperthermia (MH) susceptibility.

203 (RYR1) can cause susceptibility to malignant hyperthermia (MH), a potentially lethal genetic conditio

204 Two hours prior to hyperthermia, mice were treated with 0.6 mug intraperito

205 s of recovery time during magnetic nanofluid hyperthermia (MNFH) on the cell death rate and the heat

206 CT images were used with a patient-specific hyperthermia model to define focused ultrasound treatmen

207 MRO(2) was increased (P < 0.05) by ~20% with hyperthermia of +1.5-2.0 degrees C, this was not influen

208 media, a temperature range suitable for mild hyperthermia of solid tumors.

209 Mild hyperthermia of the tumor reduces its compact structure

210 olic rate was increased by ~20% with passive hyperthermia of up to +2 degrees C oesophageal temperatu

211 Although hyperthermia offers clinical appeal to sensitize cells t

212 In this study, we examined the effect of hyperthermia on HPV-positive cells using cervical cancer

213 ting protocols to explore the effect of mild hyperthermia on the tumor accumulation of targeted TTSL

214 proliferation than chemotherapy only and RF hyperthermia only (0.39 +/- 0.13 [standard deviation] vs

215 e tumor volume than chemotherapy only and RF hyperthermia only (0.65 +/- 0.03 vs 1.30 +/- 0.021 and 1

216 hyperthermia, (b) chemotherapy only, (c) RF hyperthermia only, or (d) phosphate-buffered saline.

217 longer growth delay than spheroids receiving hyperthermia or combination treatment at (thermal) doses

218 great value to cryopreservation of tissues, hyperthermia or cryogenic, and other thermal-based clini

219 creased compared with mice exposed to either hyperthermia or LPS alone.

220 thout altering blood chemistry or displaying hyperthermia or muscle rigor.

221 dicated that inhibiting PARylation by either hyperthermia or PARPi induced lethal DSB upon chemothera

222 ur work reveals how PARP blockade, either by hyperthermia or small-molecule inhibition, can increase

223 rasound, focal laser ablation, cryoablation, hyperthermia, or irreversible electroporation) (n = 13).

224 ifespan extension, increase of resistance to hyperthermia, oxidative stress and endoplasmic reticulum

225 Stress factors included hyperthermia, oxidative stress, and starvation.

226 o-inflammation were systemically elevated in hyperthermia (P < 0.05), there were no differences in th

227 pro-inflammatory markers will be elevated in hyperthermia, particularly in poikilocapnic hyperthermia

228 ved antidepressant effects resulted not from hyperthermia per se, but from nonspecific aspects of the

229 ed DNA (ds-DNA) is opened up to evaluate the hyperthermia performance of magnetic nanoparticles (MNPs

230 ibility of using focused ultrasound-mediated hyperthermia planning models to define treatment paramet

231 eabilizing effects of mild (40-42 degrees C) hyperthermia produced by a local RF field, we controlled

232 symptoms in pathogen host defense including hyperthermia, reduced bodily iron stores, conservation/w

233 atable gemcitabine liposomes plus ultrasound hyperthermia regressed or eliminated tumors in the neu d

234 particles in cancer treatment, the timing of hyperthermia relative to drug administration must be exa

235 ng advances in nanomedicine such as magnetic hyperthermia rely on a precise control of the nanopartic

236 Acute noradrenaline-induced hyperthermia requires UCP1 but not UCP3.

237 S) after combined chemotherapy plus regional hyperthermia (RHT).

238 In vitro and in vivo magnetic hyperthermia studies using Mg0.13 -gammaFe2 O3 nanofluid

239 pattern of physiological responses to severe hyperthermia, suggesting that early endogenous expressio

240 1 ryanodine receptor (RYR1), cause malignant hyperthermia susceptibility (MHS) and a life-threatening

241 Malignant Hyperthermia Susceptibility (MHS) exemplifies muscle con

242 tor (RYR1(T4825I/+)) confers human malignant hyperthermia susceptibility (MHS).

243 central responses to anesthesia in malignant hyperthermia susceptible mice.

244 could readily distinguish between malignant hyperthermia-susceptible and normal controls cells.

245 gnificantly higher in immortalized malignant hyperthermia-susceptible B cells treated with 0.75 mM 4-

246 5'-triphosphate degradation in the malignant hyperthermia-susceptible cells.

247 muscle relaxant succinylcholine in malignant hyperthermia-susceptible individuals.

248 mulation was markedly increased in malignant hyperthermia-susceptible lymphocytes compared with contr

249 evels were significantly higher in malignant hyperthermia-susceptible lymphocytes or immortalized B c

250 ily distinguish between normal and malignant hyperthermia-susceptible lymphocytes, independent confir

251 same Ca channel mutation found in malignant hyperthermia-susceptible muscle, we investigated agonist

252 Malignant hyperthermia-susceptible patients (n = 13) and normal su

253 compared in blood lymphocytes from malignant hyperthermia-susceptible patients and normal subjects.

254 which is used to relax muscles in malignant hyperthermia syndrome.

255 mited due to incomplete tumor eradication at hyperthermia temperature (45 degrees C). It is often com

256 y, we demonstrate that a clinically relevant hyperthermia temperature of 42 degrees C for 1 hour resu

257 While focusing on brain hyperthermia, temperature monitoring from the two periph

258 lymphocyte-adenosine protocol for malignant hyperthermia testing.

259 dose in swine CBD walls with intrabiliary RF hyperthermia than without it (gemcitabine: 0.32 mg/g of

260 n (and especially, the lower-dose reversible hyperthermia that surrounds a coagulated zone) with mech

261 bit all modes of TRPV1 activation can elicit hyperthermia, the compounds disclosed herein do not elev

262 e development for drug delivery and magnetic hyperthermia, the in vivo anti-tumor effect under a low-

263 applications, such as magnetic nanoparticle hyperthermia therapy and targeted drug delivery.

264 PV-positive cervical cancer and suggest that hyperthermia therapy could improve patient outcomes.

265 may confer advantages in cancer imaging and hyperthermia therapy.

266 therapeutic platform for non-invasive cancer hyperthermia therapy.

267 nisms of action, including thermal ablation, hyperthermia/thermal stress, mechanical perturbation, an

268 their use in combination with external local hyperthermia to achieve heat-triggered drug release.

269 of using intraesophageal radiofrequency (RF) hyperthermia to enhance local chemotherapy in a rat mode

270 results demonstrate the potential for tumor hyperthermia to increase the delivery of HSP targeted ma

271 Cooling from hyperthermia to normothermia and from normothermia to mi

272 4 +/- 0.2 L/min) decreased with cooling from hyperthermia to normothermia and mild hypothermia, where

273 -systolic volume at a pressure of 100 mm Hg (hyperthermia to normothermia: -28% +/- 3% and normotherm

274 or in diverse stress scenarios, ranging from hyperthermia to protein folding diseases.

275 ction assistance following microwave-induced hyperthermia to remove the bone tumor.

276 explaining the mechanism of action of local hyperthermia to treat viral warts.

277 , we showed that the RF method of delivering hyperthermia to tumors was more localized and uniform ac

278 he factors that influence the delivery of RF hyperthermia to tumors.

279 The combination of hyperthermia-triggered drug delivery followed by ablatio

280 therapy strategies such as thermal ablation, hyperthermia-triggered drug delivery from temperature-se

281 ve liposomes (TSL) could be obtained by mild hyperthermia-triggered release of the chemotherapeutic d

282 Adenosine formation due to malignant hyperthermia-triggering agent halothane or the ryanodine

283 /kg or ~1/5 of LD50 in rats) can cause fatal hyperthermia under environmental conditions commonly enc

284 Here we evaluate magnetic hyperthermia, using iron oxide magnetic nanoparticles, a

285 arked and immediate reversal of MDMA-induced hyperthermia via inhibition of brain metabolic activatio

286 es that induced robust locomotor activation, hyperthermia was modest in magnitude (up to approximatel

287 The hyperthermia was significantly attenuated by the beta-ad

288 In this study, tumor hyperthermia was utilized as a means to increase the act

289 al found that a single session of whole-body hyperthermia (WBH) reduced depressive symptoms; however,

290 ygen diffusion, delivery of radiation and/or hyperthermia were simulated for many ([Formula: see text

291 rousal, higher locomotor activity (LMA), and hyperthermia, which are commonly observed after acute st

292 cocele-related infertility due to testicular hyperthermia, which can result in low sperm function.

293 ought to address two hypotheses: (1) passive hyperthermia will increase the cerebral metabolic rate o

294 rosites, the risks of lethal dehydration and hyperthermia will remain low during the 21st century.

295 ated synergistic effects in combination with hyperthermia with combination index values of 0.65 and 0

296 In addition, combined hyperthermia with radiation is a very effective treatmen

297 Therefore, the combination of mild hyperthermia with the adoptive transfer of CAR T cells c

298 Hyperthermia without focused ultrasound resulted in an i

299 d and irreversible damage to tumor tissue by hyperthermia, without harming surrounding healthy tissue

300 Febrile-range hyperthermia worsens and hypothermia mitigates lung inju